FDA approves Bayer’s Finacea to treat papulopustular rosacea

Bayer HealthCare has obtained approval from the US Food and Drug Administration (FDA) for its Finacea (azelaic acid) Foam, 15% to treat inflammatory papules and pustules of mild to moderate rosacea.
Source: Pharmaceutical Technology - Category: Pharmaceuticals Source Type: news